Company to introduce the most advanced iteration of its signal processing technology at Cleveland Clinic’s Global EP Summit 2022, a world-class leadership symposiumWestport, CT, Sept. 22, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with its proprietary PURE EP™ System, today announced the release of PURE E
NEW YORK, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Taglich Brothers, Inc. announces it has initiated coverage of BioSig Technologies, Inc. (NASDAQ: BSGM). BioSig Technologies, Inc., headquartered in Westport CT, is a medical technology company that is in the early stages of commercializing an FDA–cleared product, the PURE EP™ System. This system helps electrophysiologists treat patients suffering from complex arrhythmias with a procedure called cardiac catheter ablation. The complete 18-page report is
ShockWave Medical, CheckCap and Biosig Technologies are part of The Zacks top Analyst Blog.